Orru M - Search Results

1

Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists.

Orru M, Bakešová J, Brugarolas M, Quiroz C, Beaumont V, Goldberg SR, Lluís C, Cortés A, Franco R, Casadó V, Canela EI, Ferré S. Orru M, et al. PLoS One. 2011 Jan 11;6(1):e16088. doi: 10.1371/journal.pone.0016088. PLoS One. 2011. PMID: 21264319 Free PMC article.

2

Adenosine-cannabinoid receptor interactions. Implications for striatal function.

Ferré S, Lluís C, Justinova Z, Quiroz C, Orru M, Navarro G, Canela EI, Franco R, Goldberg SR. Ferré S, et al. Among authors: orru m. Br J Pharmacol. 2010 Jun;160(3):443-53. doi: 10.1111/j.1476-5381.2010.00723.x. Br J Pharmacol. 2010. PMID: 20590556 Free PMC article. Review.

3

Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function.

Ferré S, Quiroz C, Orru M, Guitart X, Navarro G, Cortés A, Casadó V, Canela EI, Lluis C, Franco R. Ferré S, et al. Among authors: orru m. Front Neuroanat. 2011 Jun 17;5:36. doi: 10.3389/fnana.2011.00036. eCollection 2011. Front Neuroanat. 2011. PMID: 21731559 Free PMC article.

4

Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum.

Orrú M, Quiroz C, Guitart X, Ferré S. Orrú M, et al. Neuropharmacology. 2011 Oct-Nov;61(5-6):967-74. doi: 10.1016/j.neuropharm.2011.06.025. Epub 2011 Jul 5. Neuropharmacology. 2011. PMID: 21752341 Free PMC article.

5

Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.

Orrú M, Zanoveli JM, Quiroz C, Nguyen HP, Guitart X, Ferré S. Orrú M, et al. Exp Neurol. 2011 Nov;232(1):76-80. doi: 10.1016/j.expneurol.2011.08.005. Epub 2011 Aug 16. Exp Neurol. 2011. PMID: 21867705 Free PMC article.

6

Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway.

Quiroz C, Luján R, Uchigashima M, Simoes AP, Lerner TN, Borycz J, Kachroo A, Canas PM, Orru M, Schwarzschild MA, Rosin DL, Kreitzer AC, Cunha RA, Watanabe M, Ferré S. Quiroz C, et al. Among authors: orru m. ScientificWorldJournal. 2009 Nov 18;9:1321-44. doi: 10.1100/tsw.2009.143. ScientificWorldJournal. 2009. PMID: 19936569 Free PMC article.

7

Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.

Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, Moeller FG, Ferré S. Orrú M, et al. Neuropharmacology. 2013 Apr;67:476-84. doi: 10.1016/j.neuropharm.2012.11.029. Epub 2012 Dec 19. Neuropharmacology. 2013. PMID: 23261866 Free PMC article.

8

Local Control of Extracellular Dopamine Levels in the Medial Nucleus Accumbens by a Glutamatergic Projection from the Infralimbic Cortex.

Quiroz C, Orrú M, Rea W, Ciudad-Roberts A, Yepes G, Britt JP, Ferré S. Quiroz C, et al. Among authors: orru m. J Neurosci. 2016 Jan 20;36(3):851-9. doi: 10.1523/JNEUROSCI.2850-15.2016. J Neurosci. 2016. PMID: 26791215 Free PMC article.

9

Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission.

Ferré S, Orrú M, Guitart X. Ferré S, et al. Among authors: orru m. J Caffeine Res. 2013 Jun;3(2):72-78. doi: 10.1089/jcr.2013.0006. J Caffeine Res. 2013. PMID: 24761277 Free PMC article.

10

Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease.

Guitart X, Bonaventura J, Rea W, Orrú M, Cellai L, Dettori I, Pedata F, Brugarolas M, Cortés A, Casadó V, Chang CP, Narayanan M, Chern Y, Ferré S. Guitart X, et al. Among authors: orru m. Neurobiol Dis. 2016 Dec;96:47-53. doi: 10.1016/j.nbd.2016.08.013. Epub 2016 Aug 24. Neurobiol Dis. 2016. PMID: 27567601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters